Modulating intestinal neuroimmune VIPergic signaling attenuates the reduction in ILC3-derived IL-22 and hepatic steatosis in MASLD.
Autor: | Nguyen, Henry H., Talbot, Jhimmy, Dayi Li, Raghavan, Varsha, Littman, Dan R. |
---|---|
Zdroj: | Hepatology Communications; Nov2024, Vol. 8 Issue 11, p2-12, 11p |
Databáze: | Complementary Index |
Externí odkaz: |